Aims
The ReViTALISE program, funded by the Medical Research Futures Fund, aims to improve access to clinical trials (CTs) in regional Victoria. Menzies School of Health Research was commissioned to undertake a report for the ‘Aboriginal and Torres Strait Islander People* with Cancer - Clinical Trial Access Initiative’ Steering Committee (SC), to inform planning and implementation of this initiative. The SC includes consumers who are Aboriginal people, non-Aboriginal and Aboriginal health care workers and researchers.
*hereafter respectfully referred to as Aboriginal people
Methods
This report builds on a Desktop Review1 published by the Victorian Aboriginal Community Controlled Health Organisation by updating key principles and guidelines relevant to the ReViTALISE project, conducting a literature review and synthesising strategies that may increase Aboriginal people’s access to CTs.
Results
Barriers to the full participation of Aboriginal people in CTs relate to study design, gate-keeping, and mistrust of research and health institutions.
The literature reported many strategies devised to address the barriers. Consistent themes emerged, with commonalities between Australian and international literature including the centrality of addressing mistrust of research and health institutions and recognising the culturally bound nature of healthcare for Aboriginal people.
The authors developed a conceptual framework of critical strategies that have been reported as successful including: the meaningful involvement of Aboriginal people and organisations from the beginning; improved reporting of Indigenous status; overcoming gate-keeping and addressing key aspects of study design.
After review and feedback from SC, a consumer summary of the consultancy report was developed and approved by the SC, to provide an overview of the report in a concise and understandable format.
Conclusion
The report2 provides an important foundation for the ReViTALISE program to improve CT access for Aboriginal and Torres Strait Islander People with Cancer and will inform other programs of strategies to improve research design.